The upcoming 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference, taking place December 17–19, 2025 | Dubai, UAE & Virtual, is set to be one of the most influential gatherings for innovators, clinicians, researchers, and pharma leaders worldwide. The conference will serve as a premium platform to explore breakthroughs in drug development, clinical trial innovation, and digital transformation in global healthcare.
Among the distinguished speakers is Dr. Kiran N.C, a young, dedicated clinician-researcher whose growing contributions to evidence-based medicine reflect the next generation of medical leadership.
…………………………………………………………………….
“Diagnostic Accuracy of SAAG in Predicting Esophageal Varices in Cirrhosis”
At this global pharma conference, Dr. Kiran will present his research on the Serum Ascites Albumin Gradient (SAAG)—an important diagnostic indicator used to differentiate causes of ascites and assess portal hypertension in cirrhosis.
His study investigates the potential of SAAG as a non-invasive predictor of esophageal varices, one of the most serious complications of liver cirrhosis. By analyzing its diagnostic reliability, Dr. Kiran aims to support early detection, better risk assessment, and more effective patient management.
Dr. Kiran N.C completed his MBBS from Shimoga Institute of Medical Sciences and is currently a third-year Postgraduate at Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi—one of India’s largest and busiest tertiary care hospitals. His extensive clinical exposure to hepatology and gastroenterology cases has strengthened his academic insights and clinical expertise.
He has authored three case reports and delivered multiple oral paper presentations, reflecting a strong commitment to clinical research and medical advancement.
Dr. Kiran represents the new wave of clinician-scientists who bridge the gap between clinical practice and digital innovation. His research aligns with the conference’s mission to advance clinical decision-making, diagnostics, and patient outcomes through evidence-based medicine.
His presentation promises to inspire fellow clinicians, researchers, and pharma professionals by showcasing advancements in hepatology diagnostics, with direct relevance to modern clinical trials and drug development.
Dr. Kiran N.C’s participation in the 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference highlights the vital role of young researchers in shaping the future of global healthcare. His evidence-driven approach and commitment to advancing hepatology serve as a reminder that meaningful innovation comes from bridging clinical experience with scientific inquiry.
His presentation will not only enhance understanding of diagnostic tools like SAAG but will also motivate peers, researchers, and students to pursue high-impact research that improves patient outcomes.
Join us in Dubai—or connect virtually—to witness insights that advance the future of medical science, pharma innovation, and clinical research.
Join the Global Pharma Community in Dubai & Online
Conference Name: 17th Global Digital Pharma, Clinical Trials & Drug Delivery Conference
Date: December 17–19, 2025
Location: Dubai, UAE & Virtual
🔗 Visit: https://pharmacy.utilitarianconferences.com/
🔗 Register Now: https://pharmacy.utilitarianconferences.com/registration
🔗 Submit Abstract/Presentation: https://pharmacy.utilitarianconferences.com/submit-abstract
🔗 Speaker Page (Dr. Kiran N.C): https://pharmacy.utilitarianconferences.com/speaker/dr-kiran-n-c
📞 For details & registrations: +971 55179 2927
Hashtags